Building an artificial stem cell niche: prerequisites for future 3D-formation of inner ear structures-toward 3D inner ear biotechnology by de Groot, S.C. et al.
This is a repository copy of Building an artificial stem cell niche: prerequisites for future 
3D-formation of inner ear structures-toward 3D inner ear biotechnology.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/142462/
Version: Published Version
Article:
de Groot, S.C., Sliedregt, K., van Benthem, P.P.G. et al. (2 more authors) (2019) Building 
an artificial stem cell niche: prerequisites for future 3D-formation of inner ear 
structures-toward 3D inner ear biotechnology. Anatomical Record: Advances in Integrative 
Anatomy and Evolutionary Biology. ISSN 1932-8486 
https://doi.org/10.1002/ar.24067
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Building an Artiﬁcial Stem Cell Niche:
Prerequisites for Future 3D-Formation
of Inner Ear Structures—Toward 3D
Inner Ear Biotechnology
SIMON C. DE GROOT,1 KAREN SLIEDREGT,2 PETER PAUL G. VAN BENTHEM,3
MARCELO N. RIVOLTA,4 AND MARGRIET A. HUISMAN 1,3*
1Hair Science Institute, Maastricht, Maastricht, the Netherlands
2Wageningen University and Research, Wageningen, the Netherlands
3Department of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical
Center, Leiden, the Netherlands
4Centre for Stem Cell Biology, Department of Biomedical Science, University of Shefﬁeld,
Shefﬁeld, UK
ABSTRACT
In recent years, there has been an increased interest in stem cells for
the purpose of regenerative medicine to deliver a wide range of therapies
to treat many diseases. However, two-dimensional cultures of stem cells
are of limited use when studying the mechanism of pathogenesis of dis-
eases and the feasibility of a treatment. Therefore, research is focusing on
the strengths of stem cells in the three-dimensional (3D) structures mim-
icking organs, that is, organoids, or organ-on-chip, for modeling human
biology and disease. As 3D technology advances, it is necessary to know
which signals stem cells need to multiply and differentiate into complex
structures. This holds especially true for the complex 3D structure of the
inner ear. Recent work suggests that although other factors play a role, the
extracellular matrix (ECM), including its topography, is crucial to mimic a
stem cell niche in vitro and to drive stem cells toward the formation of the
tissue of interest. Technological developments have led to the investigation
of biomaterials that closely resemble the native ECM. In the fast forward
moving research of organoids and organs-on-chip, the inner ear has hardly
received attention. This review aims to provide an overview, by describing
the general context in which cells, matrix and morphogens cooperate in
order to build a tissue, to facilitate research in 3D inner ear technology.
Anat Rec, 00:000–000, 2019. © 2019 Wiley Periodicals, Inc.
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Stem cells differ from other cells in the body. In gen-
eral, stem cells have a few unique characteristics over
somatic cells; they are undifferentiated and can give rise
to differentiated daughter cells and some stem cells have
the ability to divide and renew above the Hayﬂick limit of
somatic cells (Ding and Schultz, 2004; Young et al., 2004;
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Armstrong and Tomita, 2017). These abilities are of inter-
est in the ﬁeld of regenerative medicine to repair or
renew damaged tissue (Thomson et al., 1998; Watt and
Driskell, 2010; Whiting et al., 2015). Stem cells can be
categorized into three main groups: embryonic stem cells
(ESCs), induced pluripotent stem cells (iPSCs), and adult
stem cells. Literature deﬁnes an ESC and iPSC as plurip-
otent, that is, having the capacity to form all three germ
layers: endoderm, mesoderm, and ectoderm (Grifﬁn et al.,
2015). IPSCs can be generated from mouse and human
somatic cells by artiﬁcially overexpressing four genes
(Oct3-4, Sox2, c-Myc, and Klf4 or OCT4, SOX2, NANOG,
and LIN28 (Takahashi and Yamanaka, 2006; Yu et al.,
2007). Due to their pluripotency and the ability to self-
renew, ESCs and iPSC are very suitable candidates for
regenerative medicine. However, controlling differentiation
and proliferation in vitro appeared to be challenging
(Levenberg et al., 2003). Moreover, as a consequence of
their highly proliferative nature, undifferentiated ESCs
and iPSCs are prone to develop into cancer cells, for exam-
ple, into teratoma in vivo, limiting their use in clinical tri-
als (Hentze et al., 2009; Knoepﬂer, 2009). Culture model
systems, generated from iPSCs from patients with genetic
mutations, can be used to study the onset of disease or to
explore pharmacological interventions (Qian et al., 2016).
The last group of stem cells, adult stem cells, resides in
various tissues within the body, typically at places with a
high cell turnover rate such as the gut, skin, and blood
(Wagers and Weissman, 2004). In general, adult stem
cells are multipotent, that is, they can only differentiate
within one germ layer. Mesenchymal stem cells (MSCs)
for example, are capable to differentiate toward most cells
derived from the mesodermal germ layer such as bone
marrow stroma, adipose tissue, osteocytes, and chondro-
cytes (Abdallah and Kassem, 2008). In addition, multipo-
tent stem cells have a lower proliferation rate than
pluripotent stem cells and hence adult stem cells are not
tumor-prone. For the purpose of “personalized medicine,”
adult stem cells have the advantage that they can be used
for autologous cell-based therapies. Due to the restricted
potency of adult stem cells, their capacity to grow into
organoids is limited. Nevertheless, promising results have
been achieved with culturing epithelial organoid cultures
from human intestinal crypts (Dotti et al., 2017). It has
been shown that many stem cell types are capable to dif-
ferentiate in vitro into the desired cell lineage with the
right combination of stimulatory and inhibitory factors.
However, in two-dimensional (2D) cultures, their ability
to form stable, functional cell types and complicated
structures are very limited (Kaufman et al., 2001; Reu-
binoff et al., 2001; Levenberg et al., 2003). A potentially
important issue is the difference in oxygen consumption.
In 2D cultures, all cells are exposed to the same oxygen
tension, that is, their oxygen consumption rates are
constant. This contrasts with cells in three-dimensional
(3D)-culture whereas oxygen diffuses into the complex
structure and some cells “see” less oxygen and average
consumption per cell is lower approaching rates of con-
sumption measured in vivo (Streeter and Cheema, 2011).
However, organoids should not grow too much in size, for
nutrition and oxygen supply throughout the whole tissue
becomes more challenging because organoids often lack
vascularization. Areas with poor oxygen supply and nutri-
tion often lead to differentiation of cells into an undesired
cell type and limit maturation of the organoid (Chambers
et al., 2013).
In 3D-cultures, it is key to bio-engineer the right scaf-
fold to study cellular mechanics which drive (stem) cell
fate and to study the role of the stem cell niche. The natu-
ral microenvironment of cells in vivo consists of an extra-
cellular matrix (ECM) which contains a mixture of
proteins arranged into complex topographic features that
guide cells toward their phenotype (McNamara et al.,
2010). Aside from cell specialization, the (3D) ECM is
involved in many aspects in the life of cells, such as cell
adhesion, proliferation, migration, and suppression of
inhibitory signals (Daley et al., 2008). In this perspective,
it is believed that not only biochemical but also biophysi-
cal cues such as stiffness and topography of the ECM,
together with direct cell–cell contact are of great impor-
tance in controlling stem cell fate (Yao et al., 2013; Lv
et al., 2015). Increasing evidence supports that 3D culture
in pertinent scaffolds is not only necessary to control stem
cell proliferation and differentiation but that it is also
crucial in the development of stem cells into higher order
structures such as organoids (Langer and Vacanti, 1993;
Atala, 2012). The combination of organoid and stem cell
technology is a promising concept in both developmental
and regenerative research. Importantly, the culture of
organoids helps to establish speciﬁc morphogen gradients,
which are required for the generation of tissue organoids
of a particular identity (Akkerman and Deﬁze, 2017). Cul-
turing cells in a 3D matrix enhance their expression of
differentiated functions and improve their organization
but fail to reconstitute (parts of) living organs. Another
drawback for usage of organoids in 3D culture is that
organoids can vary a lot in size and shape and those cells
deep in the organoid are hard to visualize, even with
high-resolution imaging (Bhatia and Ingber, 2014). More-
over, mimicking complicated in vivo processes such as
physiological diffusion gradients (e.g., ion transport) is
not possible. It is for these reasons that cell and disease
studies remain largely dependent on time-consuming and
costly animal studies, although these in many cases failed
to predict human responses (Huh et al., 2011). Organ-on-
chip technology may present solutions to these challenges
and the next generation of 3D cell culture models are
developed, to better mimic the microstructure, dynamic
mechanical properties, and biochemical functionalities of
whole living organs. These organs-on-chips contain multi-
ple micro-sized chips designed to simulate the physiologi-
cal conditions of tissues and organs (Bhatia and Ingber,
2014). These microﬂuidic devices allow precise control of
cells, ﬂuids, and oxygen at the nanoliter scale and facili-
tate simultaneous manipulation and analysis of cultured
cells. Hence, the possibility to control ﬂuid ﬂow in a
microﬂuidic device enhances differentiation and survival
of various cell types, including neural stem cells (Cimetta
et al., 2010; Huh et al., 2010). The use of microﬂuidic cell
culture devices can give a great advance to study tissue
development, diseases, and organ physiology (Bhatia and
Ingber, 2014). A valuable application of the organ-on-chip
model has recently been demonstrated by Wang et al.
(2014) who compared patient-derived and disease-speciﬁc
genetically engineered iPCS. Using the organ-on-chip
technique, they were able to validate the causal effect of
the genetic mutation. Another approach to tissue engi-
neering is cell sheet engineering (Auger et al., 2000).
Temperature-responsive polymers are covalently bound
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on culture dishes which allows adhesion and culture at
37C and subsequent detachment of cells. The sheet,
formed by the conﬂuent cells spontaneously detaches
when the temperature is reduced below 32C. This tech-
nique has been further developed and is 2D and 3D clini-
cally applicable now (Daley et al., 2008; McNamara et al.,
2010; Yao et al., 2013; Lv et al., 2015).
These fundamental principles of 3D culture and tissue
engineering have only recently started to be applied to
inner ear research, exempliﬁed lately in the work of
Hashino and colleagues who reported generation of
mouse and human iPSC organoids (Koehler et al., 2013;
Koehler et al., 2017). The design of models that mimic the
in vivo situation may accelerate the translation of basic
discoveries in this particular ﬁeld, as the organoid sys-
tems are a unique tool to study different diseases and
regenerative therapies of the inner ear. Moreover, this
technique could facilitate exploration of pharmacological
interventions.
This review has been undertaken to update the readers
about the progress that has been made in understanding
the mechanisms behind 3D-cell fate and is addressed to
the ﬁeld of inner ear regenerative medicine toward the
development of inner ear organoids or inner ear struc-
tures on a chip. This review highlights the signiﬁcance of
the ECM, the requirements of a 3D ECM, several bioma-
terials and some advanced production techniques of cell-
laden scaffolds. Although not speciﬁcally mentioned,
these general paragraphs are relevant to inner ear tissue
engineering. Then, the subject is directed toward the
human inner ear. Recent studies concerning the genera-
tion of inner ear organoids are discussed and we present
recommendations for future research, including the pro-
spective use of microﬂuidic cell culture systems for otic
tissue pharmacological research and bioprinting of inner
ear structures.
THE SIGNIFICANCE OF THE ECM
A (stem) cell population in vivo is in contact with a 3D
ECM that encloses multiple complex components such as
different ECM–proteins, for example, glycoproteins and
proteoglycans, a variety of endogenous growth factors and
multiple neighboring (stem) cell types. In this cell niche
all components interact, dependent on the temporal situa-
tion of the tissue. This complex system of interactions
directly inﬂuences important cell functions such as prolif-
eration, differentiation, and migration (Friedl et al.,
1998). The building blocks of the ECM are the ECM pro-
teins which determine matrix characteristics such as vis-
coelasticity, growth factor binding capacity, and
permeability to cells and nutrients. Although underesti-
mated for years, the role of the ECM has become more
and more prominent during the last two decades (Lewis,
1922; Friedl et al., 1998). To develop cells in vitro into
organoids or tissues in organoids and/or microﬂuidic sys-
tems, a microenvironment needs to be created that
mimics the ECM during embryogenesis of the particular
organ or tissue. For that purpose, knowledge about ECM
proteins during that period of time is crucial.
Throughout early development, many cells are highly
proliferative and move or sprout as organized clusters to
new locations with conserved cellular contacts (Friedl and
Gilmour, 2009; Rørth, 2011). The cell groups that migrate
may nevertheless also migrate while the epithelial
organization is maintained. This indicates the existence
of partial transitions between epithelial and mesenchy-
mal cell fate (Revenu and Gilmour, 2009). These transi-
tions are coordinated with cell–cell and cell–matrix
interaction without losing their tissue structure. Differ-
ences in cell adhesion are crucial during cell intercalation,
a process whereby cells from different layers lose contact
with their neighboring cells and rearrange into a single
layer, without losing tissue structure, owing to an
increase in surface area. Consequently, differences in
information from cell–cell contact but also cell–matrix
contact forces groups of cells to differentiate toward vari-
ous lineages. In addition, live imaging on chick embryos
with ﬂuorescent tagged ECM proteins showed a remark-
able correspondence between the epiblastic and sub-
epiblastic ECM displacements while morphogenesis pro-
ceeded. The simplest explanation is that under certain
situations, migratory cells might carry their ECM with
them. Although it is uncertain if this observation only
takes place during early development, it must be taken
into consideration that the ECM at morphogenesis is not
necessarily static in one position. These ﬁndings are com-
plementary to the work of Evseenko et al., in embroid
bodies (EBs), showing the presence and importance of
ECM proteins in the cell fate of the cells in the EB. Thus,
it has to be taken into consideration that cell fate is not
only inﬂuenced by mechanical cues caused by cell–cell
and cell–matrix contact but also by proteins, that are pre-
sent in the ECM when an embroid body has formed
(Evseenko et al., 2009).
Moreover, during embryogenesis when the different
germ layers are formed, the ECM-composition is diverse.
Among them are glycoproteins, proteoglycans, and poly-
saccharides that exert different biochemical properties
(Emerman et al., 2010). By changing various components
of the ECM, mimicking different stages in development, a
dedicated matrix could be engineered to enable lineage-
speciﬁc cell differentiation and organoid development
(Emerman et al., 2010).
SCAFFOLD REQUIREMENTS
Focal Adhesion
Focal adhesions are multi-protein structures that form
mechanical links between intracellular actin bundles and
the ﬁbers of the extracellular matrix. Focal adhesions are
composed of focal adhesion proteins (including integrins,
vinculin, talin, F-actin, and myosin) and signaling mole-
cules (including focal adhesion kinase) and are involved
in cell–matrix and cell–cell adhesion interaction
(Burridge and Chrzanowska-Wodnicka, 1996). Focal
adhesion complexes are assembled, mature and disassem-
ble to allow mechanosensing leading to a variety of cellu-
lar processes (Fig. 1). Cell–matrix adhesion often occurs
via cellular integrins, binding to an arginine–glycine–
aspartate sequence (the RGD motif) in the matrix (Wang
et al., 2013; Kenny and Connelly, 2015). Due to their
mechanosensitivity, cells can “feel” the elasticity of the
matrix, which subsequently leads to different cellular pro-
cesses. Engler et al. showed that culturing MSCs on poly-
acrylamide gels with a bone-like stiffness directed the
cells toward osteogenic differentiation and that culturing
the cells on matrices with a brain-like stiffness led to neu-
ronal differentiation. Moreover, the group demonstrated
that differentiation of stem cells occurs via focal adhesion
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by blocking nonmuscle myosin II with blebbistatin, which
is involved in tensioning of actin structures in the cyto-
skeleton. Therefore, the ability for cells to sense and
adapt to different physical microenvironments occurs via
focal adhesions and through myosin–actin contractions.
Microarray analysis found that myosin contractility plays
a critical role in lineage commitment of human MSCs
through MAPK pathways and Wnt signaling (Kilian
et al., 2010). Cells respond to a stiff matrix with more
focal adhesions compared to a soft matrix, leading to bet-
ter adhesion strength and thus stiffer/tenser cells (Legate
et al., 2009). Also, the cell’s motility increases on a stiff
matrix and cells tend to migrate from soft to stiff matrix
(Lo et al., 2000; Zhong and Ji, 2013). The high cell motil-
ity at stiff matrices, when compared to matrices of high
elasticity, is probably due to the fact that cell velocity
slows down when cells have less cell–matrix contacts in
low elasticity matrices (Wells, 2008).
In vivo, the ECM is also subject to structural changes
from cell–matrix interactions. Growing evidence suggests
that in vivo, ECM strain stiffening is caused by
surrounding cells. Strain-stiffening is deﬁned as an
increase in a material’s elastic modulus (i.e., the matrix
becomes stiffer). In natural polymers, this dynamic pro-
cess occurs primarily by increased crosslinking of collagen
and elastin and is nonlinear (Storm et al., 2005;
Lin et al., 2010). This is in contrast to most synthetic gels
and rubbers which deform linearly to large strains
(e.g., polyacrylamide). This phenomenon of nonlinear
elastic response complicates replication in synthetic
matrices.
Mechanotransduction Pathway of ECM to Cell
Nucleus
Mechanotransduction via nonmuscle myosin II seems
to play a crucial role in ECM sensing, but also other pro-
teins such as those from the Ras superfamily are known
to be involved in cytoskeleton formation, cell growth, and
transcription regulation (i.e., differentiation; Stenmark
and Olkkonen, 2001). A subgroup in the Ras superfamily
is the RhoA/ROCK pathway.
Fig. 1. Schematic illustration of the formation and remodeling of focal adhesions.The dynamic process of focal adhesion is inﬂuenced by factors
such as intercellular adhesion and morphogens. (A) At initial contact of the cells, focal adhesions assemble resulting in binding to speciﬁc adhesive
motives in the extracellular matrix. (B) Focal and intercellular adhesions are increased, leading to a variety of cellular responses. Pertinent signal
transduction pathways are upregulated, in particular, those involved in migratory processes as illustrated by changes in morphology and alignment.
These signal transduction pathways may also allow the cell to present speciﬁc receptors that bind to corresponding ligands. (C) The concerted
effect of all components allows controlled maturation and breakdown of focal adhesions resulting in coincident and coordinated movement of cells
along the extracellular matrix. Color differences represent upregulation of processes in the nucleus and cytoplasm.
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RhoA and Rock2 are proteins that are involved in the
depolymerization of actin ﬁbers and contribute to changes
in shape, adhesion, and polarity of the cell. By blocking
the RhoA/ROCK and Focal adhesion kinase (FAK) pro-
teins with speciﬁc inhibitors, changes in cytoskeletal
organization in human MSCs were observed. Studies
have also shown that RhoA/ROCK and FAK are involved
in mechanical stretching of the cell (Hirata et al., 2008;
Maharam et al., 2015).
In addition, mechanotransduction could also be initi-
ated through cell–cell adhesion by cadherins instead of
classical ECM–cell signaling. Cadherins are transmem-
brane proteins that are connected to focal adhesion pro-
teins through an alpha-catenin/beta-catenin complex
which directly binds to the actin cytoskeleton (Fig. 1;
Leckband and De Rooij, 2014).
During mechanotransduction, β-catenins are also
involved in Wnt-signaling. When epithelial-cadherins (E-
cadherins) are sequestered due to a strong cell–cell adhe-
sion, less β-catenins are available for nuclear localization
and thus less Wnt target genes can be transcribed
(Jamora and Fuchs, 2002). Wnt/beta-catenin pathway is a
mechanism that is involved in proliferation, differentia-
tion, and many other cell functions. Wnt/β-catenin
responses can also be affected by mechanotransduction
via cellular membrane integrins. Through the integri-
n/FAK pathway, beta-catenin accumulates and shuttles
to the nucleus, which can promote Wnt1 gene expression
(Du et al., 2011).
Alternatively, it has been shown that Rho kinase
2 (ROCK2) can also be responsible for the cross talk
between β-catenin, integrins, and cadherins, activating
Wnt target genes (Samuel et al., 2011). How ROCK2
sequesters β-catenin to the nucleus without effecting
E-cadherins still remains unclear.
Topography of the ECM
As mentioned above, cells actively sense their environ-
ment through ECM–cell and cell–cell contact. However,
another element appears also to be of importance: matrix
topography. When cells reside in their natural niche, they
encounter an ECM of which the ﬁber-architecture varies
in nano- and microscale. Differences in ECM architecture
on the cellular level alter cell–matrix contact, which is
another way to control cell–ECM interaction. One of the
techniques used is creating micropatterned islands. These
adhesive islands are patterned and can be created by using
microcontact printing and are substrates of a deﬁned
shape and size on a background that otherwise prevents
cell adhesion. The shape of these micropatterned islands
can be manipulated to control cell spreading and can also
be used to mimic the physiological spatial conﬁnement
thereby creating new shapes of substrates with a constant
surface adhesion area. These surfaces can be coated with
ECM in a 2D fashion where single human stem cells can
reside. Stem cells favor differentiation when placed onto
circular/spherical substrates. This indicates that the
amount and the composition of ECM is not the only initia-
tor for differentiation of stem cells but that ECM/cell shape
also takes a crucial role in stem cell fate.
In human MSCs, the intracellular response to mechan-
otransduction is different when seeded on micropatterned
islands when compared to a nonpatterned substrate. It
has also been shown that the degree of cell-spreading on
these islands by human MSCs determined their differen-
tial expression (McBeath et al., 2004). It has been
described how a smaller surface area forces human MSC
to spread to a lesser extent, resulting in a globular cell
morphology, which promoted adipogenesis (McBeath
et al., 2004). This in accordance with the report of Kilian
et al. (2010) who demonstrated that the geometric fea-
tures of MSCs can coordinate mechanochemical signals
and paracrine/autocrine factors, directing the cells toward
a speciﬁc fate (Kilian et al., 2010). Also, changing the
topography of the matrix, for example, the depth of the
cell substrate inﬂuences the rate and lineage of differenti-
ation (Zouani et al., 2012).
Usage of a ridge groove pattern on poly(dimethylsiloxane)
(PDMS) substrate has an effect on neuron development and
further differentiation into downstream lineages (Mahoney
et al., 2005). PC12 cells, a neuroblastic cell line, in vitro
placed in microgrooves of polyimide causes improved neurite
outgrowth and while for glia (Schwann cells), the groove
width was of importance for cell alignment (Miller et al.,
2001; Lietz et al., 2006). Human MSCs were aligned and
elongated along the micro-grooved poly(methyl methacry-
late) (PMMA) scaffold, immunostaining and RT-PCR showed
upregulated neural expression of MAP2, GFAP, and TUJ1
(Yim, 2007). In addition, scaffold-based delivery of neuronal
induction factors to human MSCs can result in signiﬁcant
changes in neuronal morphology and expression of the cells
when compared to controls (Yiang et al., 2012). Human
MSCs on a micro-grooved pattern of 1 μm PDMS showed an
increase of intracellular calcium which is needed for neurite
outgrowth whereas a 4 μm groove had no calcium response
(Rusanescu et al., 1995; Kim et al., 2008). Beduer et al.
(2012) found that neural stem cells, seeded on thin micro-
grooved channels, stopped proliferating and started differen-
tiation. This resulted in more polarized neurons whereas
large microgrooves lead to a higher amount of neurite out-
growth. More neurite outgrowth is essential for immature
neurons for further differentiation into neuronal lineages
(Beduer et al., 2012). It seems that a neuronal progenitor
favors to grow near the ridge of a groove in order to stimu-
late neurite development (Beduer et al., 2012). Interestingly,
when naïve human ESCs are seeded on a 350 nm ridge
grove polyurethane acrylate (PUA) substrate, the cells differ-
entiated into a neuronal lineage in 5 days without the addi-
tion of neuronal growth factors. These human ESCs were
able to differentiate into neurons but not into a glial lineage
(Lee et al., 2010). However, this study did not mention the
yield of neurons, making the outcome of the proposed
method rather uncertain. Other studies involving 400 nm
electrospun nanoﬁbers resulted in a high number of neuro-
progenitor cells and yielded many neuronal cells and mature
motor neurons from human ESC (Shahbazi et al., 2011).
Chan et al. found in stabilized culture conditions that 2 μm
grooves resulted in the best neuronal differentiation for both
human ESCs and human iPSCs. In addition to surface topo-
graphical features, which can direct cells toward neuronal
differentiation, cell geometry, and cell–cell connections are
also important issues. When cell density increases, neurite
outgrowth, and alignment is very different for the various
grooves geometries (Beduer et al., 2012). In this way, neuro-
nal networks with a controlled architecture can be designed.
Altogether it has clearly been shown that the use of topo-
graphical cues via ridge/groove patterns or ﬁbers can drive
stem cells into a neuronal lineage but the exact mechanism
still remains unknown.
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As demonstrated by Engler et al. MSCs seeded on
matrices with a soft substrate, in which the elasticity
ranges from 0.1 to 1 kPa, favor neuronal differentiation.
Further studies in stem cell fate of NSCs on a synthetic,
interfacial hydrogel culture system, showed that the best
neuronal differentiation takes place at scaffold stiffness of
0.5 kPa which is similar to the stiffness of brain tissue
(Saha et al., 2008). Furthermore, stiffness of 0.1–0.5 kPa
leads to differentiation to neurons while a stiffer matrix
of 1–10 kPa promotes glial differentiation. Also, NSCs on
a 3D alginate hydrogel enhanced TUB3 expression on the
lowest stiffness (0.5 kPa; Banerjee et al., 2009). Interest-
ingly, there are stiffness differences within the hippocam-
pus which may indicate that further differentiation into
the neuronal lineage is dependent on small differences in
ECM stiffness (Keung et al., 2011). Studies with a 3D
scaffold of hyaluronic acid and PuraMatrix™ showed that
when methacrylation of hyaluronic acid was decreased,
neurite outgrowth from dorsal root ganglia (DRG)
explants was more prominent. Methacrylation of hyaluro-
nic acid causes degradation of crosslinking which corre-
sponds with a certain degree of permeability
(Khoshakhlagh and Moore, 2015). To ensure permeability
in low elastic matrices, bio-active hydrogels with micro-
channels were produced without changing the rigidity of
the gel (Lee et al., 2015). In these gels, MSC adhere to
the gel and differentiate into neurons and glial cells
exclusively in the microchannels.
On soft matrices, neurogenic differentiation can be
modulated by inhibition of the BMP/SMAD pathway
(Du et al., 2011). Bone marrow stem cells seeded on soft
matrices express less surface integrins than on stiff
matrices. This is probably due to unstable integrin–ligand
binding on soft substrates. This unstable integrin–ECM
binding results in internalization of integrins which also
affects the localization of bone morphogenetic protein
(BMP) receptors. As a result, BMP receptor endocytosis
occurs which in turn causes repression of BMP/SMAD
pathway. The inhibition of SMAD subsequently leads to
upregulation of neuronal genes including MAP2, neuroﬁ-
lament, and nestin.
For many years, the creation of matrices focused on
sufﬁcient permeability through the whole scaffold. How-
ever, increasing evidence supports the contribution of
substrate stiffness and topography on stem cell differenti-
ation. It is therefore clear that to design the optimal
matrix for targeted stem cell differentiation, a balance
needs to be found between substrate rigidity, permeabil-
ity, and topography (Lee et al., 2015). It is recommended
to use an algorithm-based topographical biomaterial
library to ﬁnd the ideal substrate topography for instruct-
ing cell fate (Unadkat et al., 2011; Bennett et al., 2016).
BIOMATERIALS
To study cell culture in vitro, several alternatives are
presented in the literature that describes how to derive
an ECM environment mimicking the in vivo situation
(Murphy et al., 2017). The complexity of native ECM is
said to be represented best by Matrigel™ (Gelain et al.,
2006), although often hydrogels consisting of a single
ECM component, such as collagen, are applied (Kleinman
and Martin, 2005). Ideally, a pertinent scaffold should be
built which provides structural support to cells during
their lifetime and which can inﬂuence (stem) cell fate as
well. This means that, depending on the application,
some of the natural polymers have to be treated chemi-
cally in order to improve/change their stability/mechani-
cal properties. Moreover, not all of these polymers
contain adhesive sequences that may take over the role of
the in vivo ECM for in vitro cell development purposes.
Therefore, current practice is to blend two or more poly-
mers and to allow covalent binding of adhesive molecules.
For each particular tissue engineering purpose, it is pos-
sible to produce tailor-made matrices. In the process of
designing a scaffold, several aspects should be addressed.
Important features are biocompatibility and safety to
both natural and synthetic polymers. Hydrogels to be
used as a matrix should not evoke an inﬂammatory
response and may not contain harmful substances such
as pathogens. Moreover, in particular applications for
instance bioprinting, degradability, and injectability can
be an issue.
Natural Polymers
Proteins: Fibrin, silk ﬁbroin, ﬁbronectin,
laminin, and collagen. Fibrinogen is an injectable
precursor for ﬁbrin and can be generated from human
plasma, providing autologous ECM usable for organoid-
or organ-on-chip research. Polymerization of this protein
is initiated upon thrombin addition resulting in a very
ﬂexible though mechanically weak ﬁbrin meshwork
(Kneser et al., 2005). It is advantageous that a ﬁbrin net-
work is highly elastic and very stable and stiffening is
easily achieved by applying tension or compression, which
makes ﬁbrin very suitable for bioprinting (Benning
et al., 2017).
Silk ﬁbroin has proven a useful protein for developing
neuronal systems. This protein derived from cocoons of
the silkworm among others, forms packed β-sheets that
do not need crosslinking for gelation (Nagarkar et al.,
2010). In addition to this physical crosslink through
β-sheet formation, silk ﬁbroin can also be chemically
crosslinked (Elliott et al., 2015). In such a way, hydrogel
formation and mechanical properties can be controlled.
Silk ﬁbroin stiffness is comparable to brain tissue and the
stability outlasts the structural integrity of ﬁbrin and col-
lagen. To acquire adhesive properties additional mole-
cules have to be added (Hopkins et al., 2013). Due to the
soft silk ﬁbroin, this matrix is very suitable for bioprint-
ing. This has recently been shown by Das et al. (2015)
who used silk–gelatin based bio-ink loaded with mesen-
chymal stem cells and proved multilineage differentiation
and high cell viability in the matrices.
Fibronectin is a glycoprotein which is involved in cell
migration in the developing central nervous system
(Stettler and Galileo, 2004). Fibronectin also has a signiﬁ-
cant role in tissue repair because of its cell adhesion prop-
erties and its ability to sequester nutrients and growth
factors (Venstrom and Reichardt, 1993). Moreover, ﬁbro-
nectin can be secreted by different types of cells, which
increases the therapeutic potential of this glycoprotein
(Mao and Schwarzbauer, 2005). This has recently been
shown by Roberts et al. (2017) who utilized a solvent
degradable hollow ﬁber membrane as a cell culture plat-
form for 3T3 ﬁbroblasts. In such a model, the patient’s
own cells could be used to produce an appropriate matrix.
Laminin is a heterotrimeric glycoprotein composed of
alpha, beta, and gamma subunits. Laminin organizes in
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sheet-like polymers which facilitate both cell proliferation
and movement during development. In the mature cen-
tral nervous system, for unknown reasons, laminin is
mainly present in regenerative niches and along blood
vessels and remains moderately high (Liesi, 1985). Dur-
ing development and wound healing, laminin promotes
neuronal attachment and biosynthesis. Neuronal attach-
ment is procured by the amino acid sequence isoleucine,
lysine, valine, alanine, and valine (IKVAV; see also
“Adhesive (peptide) sequences” section). It has been
reported that α1β1γ1-laminin hydrogel can be produced
as an injectable hydrogel without the need of an initiator
for gelation (Francisco et al., 2013).
Collagen ﬁbrils consist of predominantly glycine repeats
buffered by two amino acid moieties, often proline and
hydroxyproline residues, and provide structure whereas both
collagen and laminin possess cell adhesive properties. To
create a 3D environment, the cells can be mixed with a liq-
uid precursor after which the suspension is allowed to poly-
merize, encapsulating the cells. The disadvantage is that the
collagen precursor is liquid below 4C, a condition harmful
for cells. Nevertheless, systems using collagen as a matrix in
a microﬂuidic system can be of great use to study cellular
migratory behavior, for example, invasion of tumor cells via
blood vessels or neurite outgrowth toward growth factor gra-
dients (Kothapalli et al., 2011; Chonan et al., 2017)
Matrigel. Matrigel™ is most often reported in
research of neuronal 3D cell culture. This hydrogel is
derived from basement cell membranes from Engelbreth–
Holm–Swarm mouse sarcoma. Matrigel™ contains all
major components such as collagen and laminin of the
in vivo ECM including growth factors and cytokines
(Kleinman and Martin, 2005). A great advantage is that it
is an approved commercial product. It has been shown that
during cultivation of inner ear hair cells when comparing
collagen type I “single component” gel to Matrigel™, the
latter outperformed in hair cell density and viability
(Spencer et al., 2008). Clearly, the fact that Matrigel™ is
rich in ECM proteins made this scaffold perform better
than just collagen type I (Spencer et al., 2008). The study
also makes a comparison with a synthetic scaffold
(PuraMatrix™, see self-assembling peptides), the latter
turns out to be the ultimate matrix of choice. In spite of its
advantages, Matrigel™ should be used with care, because
the gel harbors an undeﬁned number of growth factors that
may be advantageous, but may also vary a lot between dif-
ferent batches which could lead to inconsistent or irrepro-
ducible results (Kleinman and Martin, 2005; Hughes et al.,
2010). The same holds true for single component collagen
gel, of which biochemical and mechanical properties are
subject to batch-to-batch variations. In addition, Matrigel™
is mouse-derived and is neither safe nor practical for
human studies. Collagen and Matrigel™ hydrogels are
commonly used in injection studies although it has to be
taken into account that their sol–gel transitions require
dramatic changes in solution parameters (i.e., pH for colla-
gen and temperature for both collagen and Matrigel™).
When cells have to be encapsulated, these nonphysiological
conditions may be harmful (Parisi-Amon et al., 2013).
Polysaccharides: hyaluronic acid, alginate,
and chitosan. Another scaffold derived from nature
and frequently used in central nervous system research is
hyaluronic acid (HA) which is derived from chicken combs
or vitreous humor (Hou et al., 2005; Rosa et al., 2012).
HA is a glycosaminoglycan (GAG) and a major component
of the natural ECM. Because HA has the same mechani-
cal properties (i.e., stiffness) as brain tissue, this matrix
facilitates, when injected into the brain, stem cell engraft-
ment and survival. Moreover, it stimulates angiogenesis
without creating scar formation or tissue rejection (Hou
et al., 2005; Potter et al., 2008) and is for these qualities
already widely used in the ﬁeld of skin rejuvenation
(Bass, 2015). A disadvantage is that, in physiological
environments, HA is subjected to various degradation
processes due to hydrolysis and enzymatic hydrolysis by
naturally occurring hyaluronidase. Different strategies
such as crosslinking or conjugation have been used to sta-
bilize HA and maintaining at the same time its funda-
mental properties (Borzacchiello et al., 2015). Another
disadvantage of HA is that GAGs do not function as adhe-
sion molecules but solely add compression strength, lubri-
cation, and hydration to the ECM (Alberts et al., 2001).
HA is therefore often combined with adhesion molecules
such as poly-D-lysine (PDL), RGD-containing collagen or
heparin (Hou et al., 2005; Potter et al., 2008).
Like HA, alginate, and chitosan are polysaccharides and
do not contain adhesive motifs. For that reason, these poly-
saccharides are often blended with adhesive polymers (Hou
et al., 2005; Gwak et al., 2007; Zhong et al., 2010). Alginate
consists of mannuronic and glucuronic acid units conferring
a variable 3D structure, whereas chitosan is built up solely
from β-(1–4)-D-glucosamine monomers. The advantage of
alginate is that it is injectable, which makes it suitable for
bioprinting (Axpe and Oyen, 2016). However, the sol–gel
transition of the anionic alginate is achieved by changing
the ionic strength of the solution, which challenges cells
with nonphysiological conditions during gelation (Ionita
et al., 2015). The applications of natural and biodegradable
chitosan have been limited by the poor solubility of native
chitosan in neutral pH solution. This has been addressed
by Li et al. (2015) who incorporated a low-dose UV cross-
linking ability in chitosan, allowing fabrication of hydrogels
in which cells remain viable and can be incorporated at
physiological pH conditions (Li et al., 2015). In Table 1, all
natural polymers, their advantages and disadvantages con-
cerning 3D culturing are summarized.
Synthetic Polymers
Compared to natural polymers, synthetic polymers have
the advantage that the purity of the building blocks is
deﬁned which implies that the product can be standard-
ized and that a stable composition of the hydrogel in every
batch can be guaranteed. The fact that multiple constitu-
ents of the ECM should be present for a true mimic of the
in vivo situation, holds as much for the synthetic as for the
natural polymers. In the case of synthetic polymers, these
requirements often can be introduced in a controlled fash-
ion if a speciﬁc synthetic route is followed. On top of that,
an ideal 3D culture matrix consists of a biomaterial with
ﬁbers and pore sizes smaller than the diameter of an aver-
age cell to ensure optimal cell–cell contact and to ensure
delivery of nutrients. Especially self-assembling peptides
demonstrate the capability for tailor-made functionality
and quality by design. Interesting developments in the fab-
rication of scaffolds show potential to produce these dimen-
sions on demand (see: electrospinning).
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Polyethers, polyesters, polyacrylates, and
polyacrylamide. Many of the synthetic scaffolds are
made of single ﬁbers such as poly (2-hydroxyethyl methac-
rylate) (PHEMA), poly(ethylene glycol) (PEG), poly(acryl-
amide) (PA), and poly(epsilon-caprolactone) (PCL) (Lee
and Mooney, 2001; Rampichova et al., 2012). These micro-
ﬁbers often have a diameter of about 10–50 μm which is
similar to the diameter of most cells cultured in vitro.
Thus, when culturing cells with these microﬁber scaffolds,
different cells can adhere to one large ﬁber at the same
time, so the cells are still in a 2D environment. Moreover,
the pore size of this kind of synthetic scaffold is often 1,000
to 10,000 times larger than the microﬁber itself. A conse-
quence of engineering such a scaffold with relatively large
pore size is that extracellular factors such as hormones
and growth factors tend to diffuse away, reducing one of
the physiological properties of the ECM. On the contrary,
when a hydrogel is heavily crosslinked, the permeability of
the gel may be compromised (Lee et al., 2015).
Although polyethers, esters, and acrylates have been
proven to be helpful in cell culture studies creating a
hydrated environment of certain elasticity, their adhesive
capacity generally has to be enhanced by the (covalent)
attachment of adhesive elements or coating with e.g., a
ﬁbronectin layer.
Special attention was drawn to poly(acrylamide)
(PA) gels of different elasticity when Engler described
them in his seminal paper (2006) in which, depending
on the stiffness of PA gels, MSCs differentiated toward
osteogenic or neuronal cell types (Caliari et al., 2016).
PA hydrogels are produced by reacting acrylamide
monomer and a crosslinker, bisacrylamide, usually in
the presence of ammonium persulfate and tetramethy-
lethylenediamine. Protein conjugation to the PA hydro-
gel surface to enable cell attachment is applicable and
well-established protocols for the fabrication of PA
hydrogels with tunable stiffness and coupling of pro-
teins are available (Tse and Engler, 2010; Trappmann
et al., 2012). Therefore, PA is ideally suited for
mechanobiology studies in which hydrogel stiffness
needs to be ﬁnely controlled. A disadvantage is that
PA hydrogels do not inherently interact with cell
TABLE 1. An overview of “Biomaterials” section, natural polymers.
Natural*, ** Pro Contra
(Glyco)proteins Fibrin - Injectable
- Suitable for bioprinting
- High elasticity
- High stability
- Cell adhesive sequence***
Mechanically weak
Silk ﬁbroin - Outlasts structural integrity of Fibrin and collagen
- Controllable mechanical properties
- Suitable for bioprinting, mixture with gelatin
- Stiffness comparable to brain tissue
Adhesive properties have
to be added
Fibronectin - Cell adhesion properties ***
- Ability to sequester nutrients and growth factors
- Produced by patients own cells
- Used as a coating of synthetic polymers
Laminin - Injectable
- No need for gelation initiator
- Cell adhesive sequence both RGD and IKVAV***
Collagen - Injectable
- Cell adhesive sequence***
- Successful in microﬂuidic systems
Harmful cell encapsulation
conditions
Matrigel™ - Injectable
- Approved commercial product
- Several ECM proteins and growth factors
present
- cell adhesion properties
Harmful cell encapsulation
conditions
Polysaccharides Hyaluronic
acid
- Adds compression strength, lubrication,
and hydration to ECM
- injectable
- Control of permeability by methacrylation
- Stiffness comparable to brain tissue
- Stimulates angiogenesis
No cell adhesion motifs
Alginate - Injectable
- Suitable for bioprinting
- No cell adhesion motifs
- Variable 3D structure
- Nonphysiological conditions
during gelation
Chitosan - Antimicrobial anti-inﬂammatory
- Physiological cell encapsulation conditions when modiﬁed
- No cell adhesion motifs
- Poor solubility
Background information is indicated by symbols.
*In almost all natural polymers there is a potential risk of pathogen transmission, because most of them are derived from ani-
mal sources.
**Most natural polymers are subject to batch-to-batch variation, inhomogeneity and they are easily degraded in a physiologi-
cal environment.
***RGD adhesive motif may not always be exposed for integrin binding, this depends on the protein conformation
(Bellis, 2011).
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surface receptors or integrins. One major disadvantage
is that PA cannot be used to encapsulate cells in 3D,
because of the toxicity of the hydrogel precursors
(Caliari et al., 2016).
Self-assembling peptides. Polypeptides constitute
a different class of synthetic polymers. An effective way
to generate nanoﬁber scaffolds is the utilization of self-
assembling amphiphilic peptides. Amphiphilic peptides
are arranged as periodic repeats of hydrophilic and hydro-
phobic amino acids. When submerged in water under the
right circumstances, such as a low pH or an increasing
salt concentration, the hydrophobic part will coil up,
exposing the hydrophilic part, followed by assembly with
other (coiled) peptides into an intertwined structure.
Hence, no complex technique such as electrospinning is
needed to create a nanoﬁber scaffold. Most self-
assembling peptides designed for tissue engineering, form
bilayers in β-sheet ﬁber structures in water (Kim et al.,
2015). Nanoﬁbers of self-assembling peptides typically
have a diameter of approximately 10 nm, a 1,000 times
smaller than synthetic microﬁbers (Holmes et al., 2000).
These nanoﬁber peptides are designed at an amino acid
level so they can easily be modiﬁed, allowing for covalent
functionalization with alternative adhesive motifs. The
concentration and position of these motifs in the ﬁnal
scaffold can be meticulously controlled and ﬁnally, (stem)
cells can be encapsulated in injectable scaffolds of which
every constituent is determined. An architecture like this
is hard to achieve by means of other synthetic techniques,
while therapeutic perspectives of these pure gels are
favored over natural matrices that are undeﬁned and
may contain harmful substances/pathogens (Gelain et al.,
2006; Koutsopoulos, 2016).
RADA16 (PuraMatrix™) is a widely studied and com-
mercially available self-assembling amphiphilic peptide
that is designed to contain periodic repeats of positively
charged arginine (R) the hydrophobic alanine (A) and neg-
ative aspartic acid (D). RADA16 self-assembly is initiated
by changes in ionic strength. Gelation occurs at physiolog-
ical pH dependent on the salt concentration in the culture
medium. Temperature changes, usually needed for gela-
tion of collagen and Matrigel™, are not required. The
resulting nanoﬁbers are ordered in a similar way to
native ECM, which makes PuraMatrix™ an attractive
hydrogel for neuronal differentiation studies. Moreover,
PuraMatrix™ incorporates an adhesion motif and has
been implicated to support neuronal adhesion, promote
neurite outgrowth, and contribute synaptic formation
between the neurons in P12 cells (Holmes et al., 2000).
Formation of a vascular network, important for transport
of nutrients and oxygen in sustaining organoids, was
investigated comparing the vasculature formed by endo-
thelial stem cells and MSCs in PuraMatrix™, ﬁbrin, and
collagen type I (Allen et al., 2011). The vascular density
turned out to be far greater in PuraMatrix™, a result
attributed to this gel because it is more compliable (soft)
than ﬁbrin and collagen gels. In Table 2, all synthetic
polymers, their advantages, and disadvantages concern-
ing 3D culturing are summarized.
Adhesive (Peptide) Sequences
The presence of RGD or RGD-like adhesive units in
silk ﬁbroin, ﬁbronectin, and PuraMatrix™ was already
discussed. Techniques using phages have revealed other
short peptide epitopes, which also function as adhesive
units and among them are those relevant to neural tissue
engineering (Koss and Unsworth, 2016). One of these epi-
topes is the isoleucine–lysine–valine–alanine–valine
(IKVAV) peptide, derived from the α-1 chain of laminin.
It has been shown that hydrogels incorporated with
IKVAV hydrogel promote adhesion of PC12 cells, direct
neurite sprouting and neurite cell growth (Kam et al.,
2002; Silva et al., 2004; Wu et al., 2006). Silva et al.
(2004) found that neural progenitor cells seeded in
IKVAV hydrogel very rapidly differentiated into neurons
while no astrocyte development was found. The effect of
IKVAV in neuronal differentiation and tissue engineering
was assessed by comparing natural silk ﬁbroin hydrogel
covalently modiﬁed with IKVAV with unmodiﬁed hydro-
gel. The study showed that the hydrogel modiﬁed with
IKVAV can increase cell viability and neuronal differenti-
ation when compared with cells encapsulated with silk
ﬁbroin hydrogel alone (Sun et al., 2017). Recently, studies
with synthetic PuraMatrix™ covalently combined with
the IKVAV motif showed promising results by differenti-
ating NSCs toward neurons and astrocytes without the
addition of growth factors (Sun et al., 2016).
The ﬂexibility of peptide synthesis allows scaffold
design at the amino acid level, Sahab Negah et al. (2017),
for example, incorporated a glycine and serine residue
between the RADA16 and IKVAV peptide sequences to
grant the peptide strength.
Mixing/Blending
Both natural and synthetic polymers have their advan-
tages and limitations. While a natural polymer such as
collagen or HA possesses several properties like the
native ECM, in their isolated form they lack suitable
properties for cell survival, proliferation, or differentia-
tion, and come with bio-variation which impedes reprodu-
cing a consistent artiﬁcial ECM. On the other hand, a
synthetic polymer has deﬁned mechanical properties and
composition. Both natural and synthetic polymers need to
be enriched with adhesive peptides, normally present in a
native matrix. The polysaccharide alginate, for example,
has been mixed with collagen which contains adhesive
motifs (Lawson et al., 2004). Coassembly of an RGD with
an IKVAV epitope combines two adhesive sequences in
an attempt to arrive at a more complex ECM mimic
(Horgan et al., 2016). Controlled nanoﬁbril formation was
demonstrated resulting in a self-assembling peptide
(SAP) with bioactive characteristics and rheological prop-
erties that lie in between gel properties of the separate
peptides alone. Thus, apart from improving adhesive
properties, mixing one polymer with another adjusts the
mechanical properties of the resulting gel. Especially in
the case of synthetic polymers, a higher degree of homo-
geneity is to be expected.
Requirements of Morphogens
Cell fate can directly be inﬂuenced by the cell’s physical
microenvironment, but can also be dictated by para/auto-
crine signaling through cellular cues such as growth fac-
tors, trophic factors, and cyto- or chemokines. Stem cells
have to decide between proliferation or self-renewal and
differentiation into a more speciﬁed type of cell.
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Extracellular inducers involved in cellular differentiation
are mostly well-deﬁned molecules. Most inducers are very
potent, but still very little is known about the temporal
dynamics and expression level of the individual com-
pounds when used in vitro to ensure differentiation.
Research is ongoing in guiding stem cells toward speciﬁ-
cation while using phased procedures. For instance, Wich-
terle et al. (2002) described a detailed protocol to guide
unspecialized ectodermal cells to motor neurons in a
multi-step manner. In this protocol, induction was started
using BMP/Wnt/FGF signaling where after RA was
added. SHH was used to terminally differentiate neuro-
nal cells into motor neurons.
ADVANCED SCAFFOLD PRODUCTION
TECHNIQUES
Electrospinning of Nanoﬁbers
A relatively modern technique called electrospinning
allows the generation of ﬁbers at a nanoscale and is often
used to produce scaffolds for tissue engineering. Electro-
spinning is a process in which ultrathin, multiﬁlament
ﬁbers with diameters in the nanometer range are created
by spinning and manipulating streams of electrically
charged polymers in a strong magnetic or electric ﬁeld,
used to make specialized fabrics, such as those in space
suits (Cadogan and Shook, 2011). Many polymers can be
used to electrospin nanoﬁbers and this technique is not
limited to synthetic polymers. Naturally derived polymers
such as collagen, gelatin, and hyaluronic acid can also be
electrospun and promising results have been achieved by
using wheat protein nanoﬁbers (Woerdeman et al., 2005).
The advantage of using electrospun scaffolds is that the
major chemical, physical (pore size), and mechanical
(elasticity) properties of the ECM can be modiﬁed (Lim
and Mao, 2009). ESCs cultured in a PCL-electrospun
nanoﬁber 3D scaffold, often aggregate into EBs and after
addition of the differentiation factor, retinoic acid (RA),
these EBs can give rise to a variety of different neural cell
types: neurons, astrocytes, and oligodendrocytes (Xie
et al., 2009). Moreover, when culturing rat NSCs on an
electrospun nanoﬁber PCL scaffold, the stem cells differ-
entiated into oligodendrocytes without the addition of
neuronal growth factors (Nisbet et al., 2008). This indi-
cates that a nanoﬁber scaffold that contains PCL poly-
mers is capable to initiate differentiation of NSCs
directly, which emphasizes the importance of choosing
the right material to employ the pertinent scaffold in 3D
cell culture (Zhou et al., 2010).
Bioprinting
3D bioprinting is a method that involves the auto-
mated, spatially controlled deposition of cells and/or cell-
containing materials (often referred to as “bio-ink”) in
deﬁned patterns in 3D space (Nguyen and Pentoney Jr.,
2017). Computer-aided design technology is combined
with various techniques such as droplet-, extrusion-, or
laser-based bioprinting to create tissue constructs. Vari-
ous materials and techniques are combined to maximize
the beneﬁts. The results are promising, successful bio-
printing of cartilage, bone, cardiac, nervous, liver, and
vascular tissue has been reported (Leberﬁnger et al.,
2017). However, a major limitation to clinical translation
is building large-scale vascularized constructs. Efforts have
been made in the ﬁeld of bioprinting by vascularizing
TABLE 2. An overview of “Biomaterials” section, synthetic polymers.
Synthetic#, ## Pro Contra
Polyethers Polyethyleneglycol (PEG) - FDA approved
- High water content hydrogel
after crosslinking
- Adhesive capacity has to be
introduced
- Biodegradability has to be
improved###
Polyesters Poly(epsiloncaprolacton) (PCL) - FDA approved
- Biodegradable (lipases esterases)
- Adhesive capacity has to be
introduced
- Relatively hydrophobic
Polyacrylates Poly(2-hydroxyethylmethacrylate)
(PHEMA)
-Functional groups for introducing
adhesive functionality
- Well hydrated
- Biodegradable (75% in 17 days)
Adhesive capacity has to be
introduced
Polyacrylamides Poly(acrylamide) (PA) - Tunable stiffness
- Protocols for controlled protein
coupling available
- Adhesive capacity has to be
introduced
- Hydrogel precursor is toxic
(= not biodegradable)
Polypeptides Puramatrix™ - Intrinsic nanoﬁber scaffold hence 3D
- Encapsulation of cells under
physiological conditions
- Easily modiﬁed at amino acid level
with adhesive sequence
- Injectable
- Biodegradable
- Softer than ﬁbrin and collagen gels
Background information is indicated by symbols.
#Synthetic polymers are more strictly deﬁned than their natural counterparts and purity of components may guarantee that
no pathogens are present.
##Often microﬁbers are frequently used, but actually, this is a 2D environment.
###For instance, by incorporating matrix metalloproteinase cleavable motifs.
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tissue constructs by using microﬂuidics. Integrating 3D
printed tissue to a microﬂuidic system makes it possible to
create a multi organ-on-chip (Fig. 2). Lee and Cho (2016)
successfully bioprinted a liver-on-a-chip by combining a
microﬂuidic chip with a bioprinted hepatocyte collagen
hydrogel (Lee and Cho, 2016). The bioprinted method
showed an increased spatial heterogeneity compared to a
multistep chip fabrication such as secondary cell seeding.
Generally, when bioprinting is combined with microﬂuidic
devices, the bioprinted tissue structure is more likely to
mimic the native tissue and provides a better response in
organ-on-chip applications (Jang, 2017).
However, many challenges must be overcome before
bioprinting technology is used routinely in a clinical set-
ting (Leberﬁnger et al., 2017).
FOCUSSING ON THE INNER EAR
To generate inner ear tissue, whether in organoids or in
a microﬂuidic system, early developmental processes are of
importance from the onset of organoid culture. The early
period of inner ear development has been excellently
reviewed and hence, within the scope of organoid genera-
tion, we will brieﬂy focus on the early regionalization of
the ectoderm and the later speciﬁcation of placodal-derived
cell types (Ohyama et al., 2007; Patthey et al., 2014;
Moody and LaMantia, 2015; Basch et al., 2016).
Early Development of the Inner Ear Cell Types
Most research about early phases of inner ear develop-
ment has been performed in chicks and mice; but it seems
that placode formation is evolutionary conserved because
those results were mostly comparable, which led to the pre-
sumption that in the human inner ear placode formation
and development move along similar pathways (Uchikawa
et al., 2003). Later developmental processes are different
which is clearly shown by the difference in the start of
hearing between mice and humans; while young mice hear
after birth, the human fetus is already capable of hearing
around the third trimester of pregnancy (Locher, 2005;
Freyer et al., 2011; Fuchs and Tucker, 2015).
It has been shown that inner ear cells come from
three different sources: the otic placode, neuroepithelial
cells, and the neural crest, respectively (Freyer et al.,
2011). Placode cells and neural crest remain in close
proximity throughout their development and interact
repeatedly in a reciprocal manner (Steventon et al.,
2014). Placode cells are responsible for the sensory epi-
thelium and the spiral ganglion neurons. The descen-
dants of neuroepithelial cells account for a substantial
part of the cell population of the otic vesicle and are spe-
ciﬁcally present in proneurosensory domains. Neural
crest cells develop into the glia cells and melanocytes,
which are present in the stria vascularis. Upon their
early contact during otic placode formation, neural crest
and placode progenitors form transient contacts that
involve the accumulation of N-cadherin. These contacts
result in a local disruption of focal adhesions of placodal
cells to the extracellular matrix. It has been suggested
that neural crest cells and placode cells being succes-
sively attracting and rejecting each other build struc-
tures which eventually form the inner ear during
development (Steventon et al., 2014).
Fig. 2. Schematic representation of an organoid or organ-on-chip model. Inlet: In a controlled way, special nutrients and morphogens can ﬂow
through the chambers. Diffusion of molecules from the two lateral chambers to the central chamber, leading to binding of these molecules to the
extracellular matrix and membrane receptors, is facilitated by the semipermeable membrane between the two lateral chambers and the central
chamber. Using this model, gradients of different ligands and/or morphogens can be established in the central chamber. The central chamber can
be ﬁlled with (injectable) extracellular matrix containing organoids or mini-organs. Outlet: Medium containing CO2 and metabolic waste products
can be removed from the culture via the outlets.
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Inner Ear Development and the ECM
There are a few reports in the literature of different
ECM molecules during these early stages of mammalian
inner ear formation but to the best of our knowledge, no
report is available of the viscoelasticity of the matrix
during this period of time (Hilfer and Randolph, 1993; Vis-
conti and Hilfer, 2002). In general, during early otic pla-
code formation in vertebrates, the otic placode becomes
attached to the neural ectoderm through a single layer of
laminin (Hilfer and Randolph, 1993). From stage 10 to
stage 13, when the medial otic placode is in close contact
with the neural tube, laminin delineates each epithelial
basal surface, with ﬁne cross connections between the two
layers. By stage 14, when otic and neural layers separate
and mesenchymal cells invade the area, these thread-like
connections are no longer visible in the area where mesen-
chymal cells separate the two epithelial layers. Instead,
ﬁbronectin forms a ﬁne meshwork surrounding the invad-
ing cells (Hilfer and Randolph, 1993). Collagen IV is uni-
formly present along the entire basal length of the otic
epithelium and neural tube from before stage 10 to after
stage 14. Upon mesenchymal invasion, little collagen IV-
immunoreactivity is found in the space surrounding the
mesenchymal cells (Hilfer and Randolph, 1993). At 10 H.-
H. stage, heparan sulfate proteoglycan (HSP, syndecan)
can begin to be detected by immunolabeling on the otic
placode basal lamina, increasing markedly at 13 H.H. stage
(Moro-Balbas et al., 2000). Nevertheless, the distribution
of HSP seems to be rather limited (Visconti and Hilfer,
2002). The above-mentioned studies suggest that laminin
plays a key role in the morphogenesis of the otic primor-
dium (Visconti and Hilfer, 2002). Besides, laminin is ubiq-
uitously present as a basal lamina component in this
region of the embryo (Hilfer and Randolph, 1993). The
importance of collagen IV, ﬁbronectin and HSP during otic
placode formation, has yet to be investigated. Interest-
ingly, placodes and NC are capable to produce or induce
ECM by themselves (Gans and Northcutt, 1983).
Inner Ear Development, Cell–Cell Contact, and
Extracellular Signaling Molecules
The development of speciﬁc cell types depends also on
the spatiotemporal expression of extracellular signaling
molecules, the signal concentration, time of exposure and
combinations of different signaling molecules. Moreover,
the location and numbers of the cell receptors determine
the response of the cell. Notably, the identity adopted by a
cell in response to a signal depends on its competence to
interpret that particular signal, that is, what kind of progen-
itor cell it is. This, in turn, depends on what signals the cell
lineage has been exposed to before (Patthey and Gunhaga,
2014). This complicated speciﬁcation path holds especially
true during inner ear development and it is still not known
how different signaling pathways cooperate to establish the
speciﬁc identity of different cell types. Around gastrulation,
the ectoderm is roughly subdivided in neural and non-neural
ectoderm (Fig. 3; Streit, 2007). Interactions between these
two ectodermal ﬁelds and signals from the underlying meso-
dermal and endodermal tissues initiate the formation of an
intervening zone of ectoderm (the neural border, NB) with
the potential to form the neural crest and the preplacodal
ectoderm (PPE; Moody and LaMantia, 2015; Moody and
Saint-Jeannet, 2015). The cell population of the border
might be dynamic at the earliest stages and intermingles
with neural and epidermal precursors (in Patthey and
Gunhaga, 2014, p. 13–14). In this NB zone, cells initially
express a discrete set of genes, that is, “NB-specifying”
genes, which is required for the future expression of neu-
ral crest-speciﬁc and/or PPE-speciﬁc genes (reviewed in
Meulemans and Bronner-Fraser, 2004; Park and Saint-
Jeannet, 2010; Grocott et al., 2012). Eventually, the pre-
placodal region arises, consisting of a small U-shaped
band of ectoderm that encompasses the anterior neural
plate. All craniofacial sensory organs (nose, lens, ear, tri-
geminal, and epibranchial ganglia and lateral line) arise
from this PPE region (Ohyama et al., 2007; Streit, 2007).
This PPE receives inhibitory signals from the ecto-
derm, the neural fold and the lateral and posterior meso-
derm (Basch et al., 2016). FGF, Wnt antagonists and
BMP antagonists from the mesoderm which underlies the
preplacodal region protect the overlying ectoderm from
these inhibitory signals and allow the formation of pla-
code precursors (Singh and Groves, 2016). Speciﬁcation of
cells of the preplacodal regions, including rostral placodal
and neural crest cells, occurs in the region where neural-
promoting FGF signals and epidermal-promoting BMP
activity overlap and a certain balance between these two
signals exist. Moreover, precursor cells from different pla-
codes often overlap before they converge to their ﬁnal des-
tination and differentiate (Ohyama et al., 2007).
Furthermore, during neural tube closure, signals that
establish the anterior–posterior (A–P) axis of the embryo
also enforce a regional identity on the PPE and subse-
quently, signals from adjacent tissues cause the PPE to
separate into many discrete placodes that have distinct
developmental fates (Moody and LaMantia, 2015). Loss
and gain of functions of genes results in widening or
reduction of the preplacodal ﬁeld. Although many gene
and gene functions differ between species, it is generally
accepted that FGF signaling is involved in the formation
of a region with Pax2-expressing cells, which eventually
can give rise to the otic placode, but which can also differ-
entiate as epidermis (Ohyama et al., 2007). This domain,
marked by early otic marker genes such as Pax2 and
Pax8, has been described as the otic/epibranchial progeni-
tor domain (OEPD), distinct from the otic placode
(Whitﬁeld, 2015). After the induction of this OEPD by FGF
signals, FGF-activity has to be reduced before Wnt sig-
nals can support otic placodal development (Freter et al.,
2008; Patthey et al., 2014). The level of the canonical Wnt
signaling is critical for placode-epidermis fate decision
within the preotic ﬁeld. Cells which receive high levels of
Wnt signaling differentiate toward the otic placode, while
cells which receive little or no Wnt signaling differentiate
as epidermis. It has been suggested that Wnt signaling
can only inﬂuence the placode-epidermis fate decision in
the presence of species-dependent FGF family members
(Ohyama et al., 2007; Urness et al., 2010). Although it is
also possible that other signaling pathways such as
Notch, by regulating beta-catenin, are important to reﬁne
the border between otic placode and epidermis (Ohyama
et al., 2007). The size of the otic placode is determined
mostly through Wnt signaling while several genes such
as Pax2, Gata3, Dlx3, bone morphogenetic factor 4, coop-
erate in order to allow invagination of the otic placode to
form the otic cup and subsequently, the otocyst, which is
completely segregated from the ectoderm (Fritzsch and
Beisel, 1998; Ohyama et al., 2007; Fritzsch et al., 2015).
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During invagination, the earliest axes which arise are the
M–L axis and the A–P axis and shortly afterward the D–
V axis. A posterior retinoic acid gradient allows for the
expression of different posterior and anterior otic genes
(Bok et al., 2005; Bok et al., 2011; Janesick et al., 2015).
The neural tube provides a dorsalizing Wnt gradient,
while these dorsalizing signals are augmented by a gradi-
ent of inhibitory Gli3R. The ventral character is estab-
lished by a gradient of Shh from the notochord. During
the otic placode and otic cup stages, Wnt and Fgf gradi-
ents from the neural tube help establish a medial and a
lateral identity (Basch et al., 2016).
The otic vesicle is the origin of a diversity of cell types
in the inner ear, such as the neurons from the VIIIth
cranial ganglion, which innervate the auditory and ves-
tibular sensory hair cells. In the otic developmental pro-
gram, neurogenic/non-neurogenic fate decision is made
very early (Maier et al., 2014). Interestingly, it has been
reported that the expression of Sox10 in the otic vesicle is
similar to that in the neural crest, being affected when
FGF or Wnt8 activity is perturbed. This supports the
hypothesis that the same molecular mechanisms that
induce neural crest could be important in specifying the
placode region (Huisman and Rivolta, 2012)
In vitro research of the generation of human
inner ear progenitors (temporal dynamics). The
principle of patterning used by Wichterle also holds true
Fig. 3. Overview of the different stages during inner ear development from gastrulation to otocyst formation. The pertinent signaling pathways
involved are mentioned.
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for inner ear development (Fritzsch et al., 2015). Differen-
tiation of pluripotent stem cells into the early otic ecto-
derm requires suppression of the endodermal and
mesodermal lineage. This can be achieved by inhibiting
the TGF-β and BMP4 and activating the FGF signaling
pathways (Matsuoka et al., 2017). As mentioned in the
protocol of Koehler and Hashino (2014), these signaling
pathways are signiﬁcant inducers of formation of the otic
vesicle. Not only the concentration is of importance, the
spatiotemporal pattern of many growth factors and mor-
phogens including BMPs and FGFs are critical in the gen-
eration of inner ear progenitor cells. For example, BMP4
could only be added in a small-time window as neuronal
fate at day 5 has not the same effect as at day three.
Moreover, BMP4 signaling needed to be inhibited
24–48 hr after induction to ensure a proper preplacodal
ectoderm (PPE) as it happens the same in the in vivo
mouse embryo (Kwon et al., 2010; Koehler and Hashino,
2014). FGF signaling is needed to transform the PPE
toward the OEPD which contains PAX2 positive cells. In
this stadium, specialization can go toward otic and epi-
branchial direction. The differentiation toward otic line-
age depends on the duration and strength of FGF and
Wnt signaling (Freter et al., 2008). Nevertheless, otic pro-
genitors can be induced from pluripotent stem cells by
activating FGF signaling with ligands involved in the
generation of the placode in vivo, such as FGF3 and
FGF10 (Chen et al., 2012). Alternatively, inner ear pro-
genitors can be generated in vitro, from other stem cell
populations, circumventing the above-described procedure
of stepwise addition of signaling molecules (Boddy et al.,
2012). Human mesenchymal stem cells were cultured in
media which previously has been used to culture human
fetal auditory cells. This conditioned medium, induced
the expression of otic progenitor markers, such as PAX8,
PAX2, GATA3, and SOX2, while epithelial and neuronal
otic precursors were morphologically distinguishable.
After prolonged culture, cells coexpressed either indica-
tors of hair cell lineage or neuronal markers such as
NEUROG1, POU4F1, and NEFH.
Inner Ear Organoids
Since the growing interest in the use of 3D-matrices in
cell culture, fast progress has been made in the genera-
tion of cerebral organoids. Lancaster et al. (2013) devel-
oped a neural organoid that contained various discrete,
interdependent, brain regions. After culture of human
iPSCs, using a low FGF concentration, EBs were formed.
These EBs were cultured in neuronal induction medium
and when neurectoderm formation started, the EBs were
placed in a Matrigel™ droplet. Neuronal differentiation
was initiated, using different generally used pertinent
bioreactive factors. Then, the newly generated neurecto-
derm in the matrigel™ droplet was placed in a spinning
bioreactor to provide a 3D low-shear stress suspension
culture where differentiation was completed and distinct
brain regions, including hippocampus were formed after
30 days (Lancaster et al., 2013). During this period of
time, the same cocktail of bioreactive factors including
retinoic acid was added to the culture. Recently, the work
of Lancaster was reﬁned using a miniaturized spinning
bioreactor with iPSCs, eluding the problem of large
(expensive) medium volume (Qian et al., 2016). The group
also developed a protocol to generate cerebral organoids
in a more reproducible and quantiﬁable manner. Cur-
rently, this protocol, sometimes more or less modiﬁed by
others, is a general procedure to achieve brain organoids.
Koehler and Hashino (2014) developed a 3D culture
protocol to differentiate ESCs toward inner ear organoids
that contained sensory epithelia hair cells. This protocol
is more or less similar to the general principle used by
Lancaster and others and largely based on the method
developed by Eiraku et al. (2011) for optic cup organoids.
It includes generation of an EB, initiation of neurecto-
derm formation and 3D culture to further develop the
organoid. Later studies with the protocol of Koehler et al
on inner ear organoids showed that hair cells found on
the organoids developed mechanosensitivity as native
hair cells in mice (Liu et al., 2016). Koehler, like many
others in organoid research, used matrigel. To the best of
our knowledge, studies in which organoids are generated
using other matrices are yet not available.
CONCLUSION AND PERSPECTIVE
Although it was known for years that the ECM played
a crucial role during differentiation of cells, recent discov-
eries have revealed various cellular mechanisms that
drive stem cell fate, such as mechanotransduction
through focal adhesions. Increasing effort has been
undertaken to create an artiﬁcial scaffold for stem cells
that mimics that native ECM in the best possible ways.
Promising steps were made with the use of self-assembled
peptides that makes it possible to build an artiﬁcial ECM
from the ground up, that is, at amino-acid level.
Researchers already implement ECM motifs in the design
of self-assembled peptides to enhance differentiation
toward a certain germ-layer (i.e., neuronal differentia-
tion). As ECM research in self-assembled peptides such
as RADA16 progress, more motifs could successfully be
incorporated in the scaffold which makes it possible to
direct stem cells toward more complex structures. Despite
signiﬁcant progress in research of synthetic scaffolds,
these self-assembling peptides remain a minority among
matrices used in 3D culture. Control of topography and
rigidity, in combination with techniques such as spinning
bioreactors and microﬂuidic devices, made it possible to
successfully culture complex structures such as cerebral
organoids.
However, many limitations in culturing organoids still
need to be overcome, because aspects as shape and struc-
ture, cross-tissue communication, and patterning still do
not resemble the native in vivo situation. As previously
mentioned, when organoids grow in size, their maturation
is limited due to poor oxygen supply and nutrition within
deeper layers of the organoid (Chambers et al., 2013). To
solve this problem, vascular endothelial growth factors
(VEGFs) could be implemented into the scaffold to promote
neoangiogenesis in the organoid (Richardson et al., 2001).
Nevertheless, it is generally accepted that microﬂuidic
devices can solve hyponutrition and hypoxia by integrating
a controlled release of signal gradient and a constant sup-
ply of nutrients and oxygen. The disadvantage is that
these systems are expensive and laborious and for that
reason, they are more or less exclusively reserved for well-
equipped laboratories. Nevertheless, to study development
and disease, organoids from patients own (stem) cells can
be generated and explored by almost all laboratories.
Pharmacological studies, the establishment of drug effects
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on the target- and perhaps also in combination with other
organs, will need the use of microﬂuidic systems because
of large numbers of tests required.
It is a key in bioengineering to combine several strate-
gies when culturing complex higher order structures at
cellular, tissue and organ level. Working with multiple
cell types in vitro requires reﬁnement in spatial and tem-
poral instructions for a more coordinated differentiation.
Considerable progress in regenerative medicine has been
made regarding organoid and organ-on-chip culturing by
controlling external cues, but still many challenges have
to be overcome. It is of importance to realize that matri-
ces need to be designed in such a way that spatial and
temporal signaling can be controlled to guide differentia-
tion and patterning of speciﬁc areas. Moreover, encapsu-
lating cells within a matrix during polymerization of the
scaffold may be beneﬁciary as opposed to letting cells
“sink in” to their 3D environment (Nicodemus and Bry-
ant, 2008).
The inner ear is one of the most complicated organs in
the body, consisting of two related but also differently
functioning parts: the cochlea and the vestibular system.
To build an inner ear from human stem cells requires
coupling of both the organoid of the cochlea and that of
the vestibular system. Hence, a system with the capacity
to support many different cell types. This may be a feasi-
ble approach as exempliﬁed in cultures with two (and
more) connected mini-organs that were realized using
microﬂuidic systems (Rogal et al., 2017). Developmental
processes of the cochlea and/or vestibular system could be
studied separately in organoid models. Subsequently,
these organoids could be combined into a single microﬂui-
dic system to serve pharmacological research purposes.
It will be interesting to see how inner ear progenitor
cells (Chen et al., 2012) when cultured in organoid or
microﬂuidic culture, can be directed toward higher inner
ear structures. Inner ear (progenitor) cells, whether or
not (pre)differentiated in an organoid, could also be used
for bioprinting purposes in which different cells and gra-
dients of ECM can be merged. For this purpose pertinent
types of ECM could be chosen, such as laminin and colla-
gen both involved in inner ear development. To achieve
the desired characteristics, for example, elasticity, these
matrices could be blended with suitable biodegradable
synthetic hydrogels. A certain mixture of polymers would
allow changes in the composition of the matrix in time
and it is conceivable that matrix alterations can be pro-
grammed, mimicking the native situation. In that per-
spective, self-assembling peptide matrices have numerous
advantages. They are synthesized via standard protocols
and covalent incorporation of adhesive elements of choice,
such as RGD or IKVAV, can be implemented on demand.
They allow for 3D encapsulation of cells and frequently
are injectable. Most importantly is the safety aspect: bio-
logical batch variability does not occur and these matrices
are produced without animal components.
PuraMatrix™ is such a self-assembling peptide in
which the peptide sequence is assumed to have adhesive
properties, which can be useful when no speciﬁc adhesive
elements are needed. Both, Matrigel™ and PuraMatrix™
have the right matrix stiffness for inner ear organoids,
microﬂuidic research, or bioprinting. Nevertheless, there
are many opportunities to move further forward into this
exciting ﬁeld of inner ear research which has only just
started.
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